FluoSphera
Advanced 3D and multi-tissue biology for predictive drug discovery.
About FluoSphera
Ready-to-use microtissues for efficacy, safety, DMPK-Tox & biomarker studies.
Recent Funding lists FluoSphera under Health and bio. It went through IndieBio (IndieBio NY 05). It was founded by Clélia Bourgoint, Aurélien Roux and Gregory Segala.
Funding rounds
- IndieBio NY 05
IIndieBio · batchSource: indiebio.co - Website created
- X account created
Founders and team
CB
Clélia Bourgoint CEO, Chair & Co-Foundersource: fluosphera.comAR
Aurélien Roux Scientific Advisor & Co-Foundersource: fluosphera.comGS
Gregory Segala CSO & CO-foundersource: fluosphera.com
Investors
Similar Health and bio companies
HHexagon Bio$62M Series B+ · Oct 2026
BBioStack$9.5M Seed · Oct 2026HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026
WWarp Sciences$215M Series A · Oct 2026
PPAM2L Biotechnologies$29.97M Series A · Oct 2026
Questions and sources
FluoSphera: questions and answers
- Who invested in FluoSphera?
- Investors on record for FluoSphera: IndieBio.
- Who founded FluoSphera?
- FluoSphera was founded by Clélia Bourgoint (CEO, Chair & Co-Founder), Aurélien Roux (Scientific Advisor & Co-Founder) and Gregory Segala (CSO & CO-founder).
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/fluosphera (get a free API key).